Microprocessor in controlled transdermal drug delivery of anti-cancer drugs

Journal of Materials Science: Materials in Medicine

Volumn 20, Issue SUPPL. 1, 2009, Pages

  Chandrashekar, N S ^a   Shobha Rani, R H ^a  

^a AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

5-FLUOROURACIL (5-FU); 6-MERCAPTOPURINE; ADHESIVE PROPERTIES; ANTICANCER DRUG; CURRENT INCREASE; CURRENT PHASE; DIFFUSION STUDIES; DRUG CONCENTRATION; DRUG CONTENT; DRUG PERMEATION; EFFECTIVE CONCENTRATION; FOLDING ENDURANCE; HUMAN CADAVER SKINS; IN-VITRO; IN-VITRO EVALUATION; LAG-TIME; MICROPROCESSOR CONTROLLED; OHM'S LAW; PHARMACOKINETICS PARAMETERS; SKIN RESISTANCE; TRANSDERMAL; TRANSDERMAL DELIVERY; TRANSDERMAL DRUG DELIVERY;

DRUG PRODUCTS; MICROPROCESSOR CHIPS;

CONTROLLED DRUG DELIVERY;

ANTINEOPLASTIC AGENT; FLUOROURACIL; MERCAPTOPURINE;

ADHESION; CADAVER; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; HUMAN; IN VITRO STUDY; MICROPROCESSOR; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN CONDUCTANCE; THICKNESS; TRANSDERMAL DRUG ADMINISTRATION; TRANSDERMAL PATCH;

6-MERCAPTOPURINE; ADMINISTRATION, CUTANEOUS; ANTINEOPLASTIC AGENTS; CADAVER; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG DELIVERY SYSTEMS; ELECTRIC IMPEDANCE; FLUOROURACIL; HUMANS; MICROCOMPUTERS; SKIN; SKIN ABSORPTION;

EID: 75049086154     PISSN: 09574530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10856-008-3510-6     Document Type: Conference Paper

References (20)

1. Y.W. Chein, Novel Drug Delivery Systems Revised and Expanded, 2nd edn. (Marcel Dekker Inc., New York, 2005), pp. 301-380
2. JA Subramony A Sharma JB Phipps 2006 Microprocessor controlled transdermal drug delivery Int. J. Pharm. 317 1 6 10.1016/j.ijpharm.2006.03.053 10.1016/j.ijpharm.2006.03.053 1:CAS:528:DC%2BD28XlsFClsLk%3D 16713690 (Pubitemid 43866349)
3. E.R. Scott, J.B. Phipps, J.R. Gyory, R.V. Padmanabhan, Electrotransport systems for transdermal delivery. A practical implementation of iontophoresis, in Handbook of Pharmaceutical Controlled Release Technology, ed. by D.L. Wise (Marcel Dekker Inc., New York, 2005), pp. 617-657
4. CTS Ching I Camilleri P Conoll 2005 A low-cost programmable device for versatile current delivery in iontophoresis applications Sens. Actuators 106 534 540 10.1016/j.snb.2004.07.022 10.1016/j.snb.2004.07.022 (Pubitemid 40557611)
5. W Bleyer 1988 Central nervous system leukemia Pediatr. Clin. North Am. 35 789 814 1:STN:280:DyaL1czjsFCnsA%3D%3D 3047654
6. B Bostrom G Erdmann 1993 Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia Am. J. Pediatr. Hematol. Oncol. 15 80 86 10.1097/00043426-199302000-00024 10.1097/00043426-199302000-00024 1:STN:280:DyaK3s7ptFehtg%3D%3D 8447563
7. C Cuffari S Hunt TM Bayless 2000 Enhanced bioavailability of azathioprine compared to 6-mercaptopurine therapy in inflammatory bowel disease: correlation with treatment efficacy Alim. Pharmacol. Ther. 14 1009 1014 10.1046/j.1365-2036.2000.00812.x 10.1046/j.1365-2036.2000.00812.x 1:CAS:528:DC%2BD3cXms1ykuro%3D (Pubitemid 30618161)
8. J Romagnuolo DC Sadowski E Lalor L Jewell AB Thomson 1988 Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity Can. J. Gastroenterol. 12 479 483
9. JM Joulia F Pinguet M Ychou J Duffour C Astre F Bressolle 1999 Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus continuous infusion with high-dose folinic acid Eur. J. Cancer 35 296 301 10.1016/S0959-8049(98)00318-9 1:CAS:528:DyaK1MXisVagtbg%3D 10448274 (Pubitemid 29136782)
10. C Zinutti M Barberi-Heyob M Hoffman P Maincent 1998 In-vivo evaluation of sustained release microspheres of 5-FU in rabbits Int. J. Pharm. 166 231 234 10.1016/S0378-5173(98)00040-4 1:CAS:528:DyaK1cXjslGlt7w%3D (Pubitemid 28255231)
11. RB Diasio BE Harris 1989 Clinical pharmacology of 5-fluorouracil Clin. Pharmacokinet. 16 215 237 10.2165/00003088-198916040-00002 1:CAS:528: DyaL1MXkslSisr4%3D 2656050
12. NS Chandrashekar RH Shobha Rani 2007 Cytotoxicity, anti-tumor activity, cumulative skin irritation and sensitization study of 5-fluorouracil from a transdermal patch for Dalton's lymphoma ascites cells J. Health Sci. 53 275 281 10.1248/jhs.53.275 1:CAS:528:DC%2BD2sXntVCksrY%3D (Pubitemid 46855595)
13. AM Kligman E Christopher 1963 Preparation of isolated sheets of human stratum corneum Arch. Dermatol. 88 70 73
14. M Aqil A Ali Y Sultana AK Najmi 2004 Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil Pharmazie 59 631 635 1:CAS:528:DC%2BD2cXmvVentLk%3D 15378854
15. DA Dimas PP Dallas DM Rekkas NH Choulis 2000 Effect of several factors on the mechanical properties of pressure-sensitive adhesives used in transdermal therapeutic systems AAPS PharmSciTech. 1 2 E16 10.1208/pt010216 1:STN:280:DC%2BD2c%2FivVOksw%3D%3D 14727849
16. K Sudeji M Kawasaki H Inada K Kattayama M Kakemi T Koizumi 1989 Enhanced percutaneous absorption of fomoterol fumarate via pulsed iontophoresis. I. Effects of constant current and constant voltage Yakugaku Zasshi 109 766 770 1:CAS:528:DyaK3cXkt1eluw%3D%3D 2621565 (Pubitemid 19273233)
17. Y Merino A Lopez YN Kalia RH Guy 1999 Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil Pharm. Res. 16 758 761 10.1023/A:1018841111922 1:CAS:528:DyaK1MXjt1yit7c%3D 10350021 (Pubitemid 29227108)
18. AR Denet R Vanbever V Preat 2004 Skin electroporation for transdermal and topical delivery Adv. Drug Deliv. Rev. 56 659 674 10.1016/j.addr.2003.10.027 1:CAS:528:DC%2BD2cXhvFWqsbg%3D 15019751 (Pubitemid 38326938)
19. AC Hirsch RS Upasani AK Banga 2005 Factorial design approach to evaluate interactions between electrically assisted enhancement and skin stripping for delivery of tacrine J. Control Release 103 113 121 10.1016/j.jconrel.2004.11.026 1:CAS:528:DC%2BD2MXhtleqtLw%3D 15710505 (Pubitemid 40248566)
20. Y Fumiyoshi K Yasuo K Megumi T Yoshinobu H Mitsuru 1995 Analysis of in vivo skin penetration enhancement by oleic acid based on a two-layer diffusion model with polar and nonpolar routes in the stratum corneum Int. J. Pharm. 117 173 179 10.1016/0378-5173(94)00327-2